Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.
about
Autophagy in Chronic Kidney DiseasesAutophagy: A Novel Therapeutic Target for Diabetic NephropathyAn Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of ResveratrolAutophagy in kidney health and disease.Resveratrol inhibits the epithelial sodium channel via phopshoinositides and AMP-activated protein kinase in kidney collecting duct cellsRisperidone-Induced Renal Damage and Metabolic Side Effects: The Protective Effect of ResveratrolResveratrol increases nitric oxide production in the rat thick ascending limb via Ca2+/calmodulinAutophagy in diabetic nephropathyResveratrol ameliorates cardiac dysfunction induced by pressure overload in rats via structural protection and modulation of Ca(2+) cycling proteins.Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase.Signaling mechanisms in the regulation of renal matrix metabolism in diabetes.EGCG-mediated autophagy flux has a neuroprotection effect via a class III histone deacetylase in primary neuron cells.Extract of Rhizoma Polygonum cuspidatum reduces early renal podocyte injury in streptozotocin‑induced diabetic rats and its active compound emodin inhibits methylglyoxal‑mediated glycation of proteins.Sugar, sex, and TGF-β in diabetic nephropathy.Resveratrol Ameliorates Diabetes-induced Renal Damage through Regulating the Expression of TGF-β1, Collagen IV and Th17/Treg-related Cytokines in Rats.Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compoundsInduction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease.Resveratrol Prevention of Diabetic Nephropathy Is Associated with the Suppression of Renal Inflammation and Mesangial Cell Proliferation: Possible Roles of Akt/NF-κB Pathway.Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy.Autophagy as a therapeutic target in diabetic nephropathy.Pathophysiology of the aging kidney and therapeutic interventions.Sirtuins' modulation of autophagy.Interventions against nutrient-sensing pathways represent an emerging new therapeutic approach for diabetic nephropathy.Renal protective effects of resveratrol.Natural polyphenols based new therapeutic avenues for advanced biomedical applications.Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles.Isoangustone A suppresses mesangial fibrosis and inflammation in human renal mesangial cells.Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway.Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential.Estrogen receptor subtype ratio change protects against podocyte damage.Resveratrol-loaded nanoparticles conjugated with kidney injury molecule-1 as a drug delivery system for potential use in chronic kidney disease.Resveratrol provides benefits in mice with type II diabetes-induced chronic renal failure through AMPK signaling pathway.
P2860
Q26740427-6AFBDF7C-8C04-4394-9D04-DE18A7F149C4Q26771919-F4093262-8551-4C1D-97A3-44804043E5A4Q26800907-4EB13D74-97A5-4CE1-A179-FC8125CB6D6EQ27687496-4FFA085A-011B-4744-9733-3316BAD8F680Q28534677-3EACD327-2000-47AC-96F4-41B887DE0A35Q33863719-7311126B-3B47-4D53-9830-1244668A1A08Q34338591-F53030F8-E548-455C-BCD9-E84EDD101634Q34445143-A4FCEC6A-4A33-4860-B119-D3DA2D9404A1Q34782924-3679F407-1F64-4734-B508-5C45AE4F1BBCQ35147432-931A5D1D-86B4-4F91-9F8E-29CD041EAE04Q35791976-32A8F8E3-3D08-4FD2-AFB9-922B155976B6Q35833116-7D0BF54F-1922-404A-85D3-A628949D955DQ36089679-FE9A51C9-8E99-4D22-B27B-AD1CDEA4592CQ36234919-40EE1164-E7EB-4D30-92F8-0B635F4168F9Q36306351-D2C0D902-1A19-4E51-B309-0B557A48681FQ36801780-14D747E9-0ACC-4CDA-9104-96583A7FAB67Q37142481-6AED8853-08E2-4DC6-902F-DBACD8ECFC21Q37615803-E4EBC441-6BF4-42E8-BD23-66B39A101D75Q37736609-48467E81-6C6F-4240-A2C7-88627DBB8560Q37949588-A4C9E835-5B82-403A-8A06-6BF28966EC61Q38053074-E0ECD33E-2A20-4B0A-BC0F-186530BCDD96Q38108575-E1EB7181-F115-4FA5-95C6-15AF0C853B6BQ38162106-CEA16F1F-F1FF-4680-A4FE-016AE25B86E3Q38174888-FF07AF2B-10AE-481B-8862-E6353B6DCE8CQ38622865-F28EAFD0-0ABB-4EB6-AE2F-65D1ACB79295Q39321120-A87392B6-806D-405B-A516-F75B7533065CQ42747749-F5306444-89BB-4521-A9ED-F73E7FDEBDEAQ46131293-476DF85A-4856-4A50-B540-1AE873A66299Q46312225-216D2C72-79A3-4C0E-8621-E37EEB6D12C6Q47549327-83BB5266-6F32-4631-B69B-07EB13329074Q48666820-1BD01904-3082-4271-93B6-C9AA643A7E4CQ55286919-5CD7BF1A-C413-497C-84CA-92E7FF519CE1
P2860
Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.
@en
Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.
@nl
type
label
Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.
@en
Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.
@nl
prefLabel
Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.
@en
Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.
@nl
P2093
P356
P1476
Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK
@en
P2093
Ai-Ping Hu
Da-Fa Ding
Jia-Rong Xu
Xiao-Long Ye
Xiao-Mei Wu
Xiu-Qing Jiang
P304
P356
10.1159/000300388
P50
P577
2010-03-20T00:00:00Z